Apyx Medical (APYX) Change in Receivables (2011 - 2026)

Apyx Medical's Change in Receivables history runs 16 years deep, the most recent figure standing at -$4.0 million for Q1 2026.

• Quarterly Change in Receivables changed 0.25% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 404.9% YoY) and the FY2025 annual result came in at $1.3 million, down 35.23% from the prior year.
• Change in Receivables was -$4.0 million for Q1 2026 at Apyx Medical, down from $3.9 million in the prior quarter.
• Across five years, Change in Receivables topped out at $3.9 million in Q4 2025 and bottomed at -$4.0 million in Q1 2026.
• A 5-year average of $62176.5 and a median of $291000.0 in 2024 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 496.1% in 2025, while the deepest fall reached 261.86% in 2025.
• Apyx Medical's Change in Receivables stood at $1.4 million in 2022, then gained by 1.99% to $1.4 million in 2023, then surged by 110.85% to $2.9 million in 2024, then soared by 33.67% to $3.9 million in 2025, then plunged by 201.46% to -$4.0 million in 2026.
• Business Quant data shows APYX's Change in Receivables at -$4.0 million in Q1 2026, $3.9 million in Q4 2025, and $1.8 million in Q3 2025.